Genetic profiling predicts prostate cancer relapse

University of Cambridge researchers have identified five genetic types of prostate cancer which should eventually help clinicians decide on treatment.

Combining two genetic techniques, they classified prostate biopsy samples from 156 British men into five groups on the basis of the activity levels of 100 “discriminating” genes.

Two groups had markedly more genome abnormalities